Nicorandil improves cardiac function and clinical outcome in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: Role of inhibitory effect on reactive oxygen species formation

American Heart Journal

Volumn 148, Issue 4, 2004, Pages 611-7

  Ono, Hirotsugu ^a   Osanai, Tomohiro ^a   Ishizaka, Hiroshi ^a   Hanada, Hiroyuki ^a   Kamada, Takaatsu ^a   Onodera, Hiroyuki ^a   Fujita, Norio ^a   Sasaki, Shingo ^a   Matsunaga, Toshiro ^a   Okumura, Ken ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; NICORANDIL; REACTIVE OXYGEN METABOLITE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BOLUS INJECTION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FLOW MEASUREMENT; HEART FUNCTION; HOSPITALIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPERFUSION INJURY; TREATMENT OUTCOME; URINARY EXCRETION;

EID: 5344281111     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2004.05.014     Document Type: Article

References (28)

1. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet. 1:1986;397-402
2. ISIS-2 (Second International Study Group of Infarct Survival) collaborative group. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction. Lancet. 2:1988;349-360
3. Grines C.L., Browne K.F., Marco J., et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med. 328:1993;673-679
4. Stone G.W., Grines C.L., Browne K.F., et al. Predictors of in-hospital and 6-month outcome after acute myocardial infarction in the reperfusion era: the primary angioplasty in myocardial infarction (PAMI) trial. J Am Coll Cardiol. 25:1995;370-377
5. Zijlstra F., Hoorntje J.C.A., de Boer M.J., et al. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med. 341:1999;1413-1419
6. Kloner R.A. Does reperfusion injury exist in humans? J Am Coll Cardiol. 21:1993;537-545
7. Guan W.P., Osanai T., Kamada T., et al. Time course of free radical production after primary coronary angioplasty for acute myocardial infarction and the effect of vitamin C. Jpn Circ J. 63:1999;924-928
8. Klein H.H., Pich S., Lindert-Heimberg S., et al. Failure of chronic, high-dose, oral vitamin E treatment to protect the ischemic, reperfused porcine heart. J Mol Cell Cardiol. 25:1993;103-112
9. Janero D.R. Therapeutic potential of vitamin E against myocardial ischemic-reperfusion injury. Free Radic Biol Med. 10:1991;315-324
10. Auchampach J.A., Cavero I., Gross G.J., et al. Nicorandil attenuates myocardial dysfunction associated with transient ischemia by opening ATP-dependent potassium channels. J Cardiovasc Pharmacol. 20:1992;765-771
11. Lamping K.A., Christensen C.W., Pelc L.R., et al. Effect of nicorandil and nifedipine on protection of ischemic myocardium. J Cardiovasc Pharmacol. 6:1984;536-542
12. Ito H., Taniyama Y., Iwakura K., et al. Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction. J Am Coll Cardiol. 33:1999;654-660
13. Sugimoto K., Ito H., Iwakura K., et al. Intravenous nicorandil in conjunction with coronary reperfusion therapy is associated with better clinical and functional outcomes in patients with acute myocardial infarction. Circ J. 67:2003;295-300
14. Pieper G.M., Gross G.J. Anti-free-radical and neutrophil modulating properties of the nitrovasodilator, nicorandil. Cardiovasc Drugs Ther. 6:1992;225-232
15. Yasu T., Ikeda N., Ishizuka N., et al. Nicorandil and leukocyte activation. J Cardiovasc Pharmacol. 40:2002;684-692
16. Pratico D., Lawson J.A., FitzGerald G.A. Cyclooxygenase-dependent formation of the isoprostane, 8-epi-prostanglandin F2a. J Biol Chem. 270:1995;9800-9808
17. Delanty N., Reilly M.P., Pratico D., et al. 8-epi-prostanglandin F2a generation during cononary reperfusion: a potential quantitative marker of oxidant stress in vivo. Circulation. 95:1997;2492-2499
18. Reilly M.P., Delanty N., Roy L., et al. Increased formation of the isoprostanes IP F2a-I and 8-epi-prostanglandin F2a in acute coronary angioplasty: evidence for oxidant stress during coronary reperfusion in humans. Circulation. 96:1997;3314-3320
19. Guan W.P., Osanai T., Kamada T., et al., Effect of allopurinol pretreatment on free radical generation after primary coronary angioplasty for acute myocardial infarction. J Cardiovasc Pharmacol. 41:2003;699-705
20. Hashimoto K., Kinoshita M., Ohbayashi Y. Cononary effects of nicorandil in comparison with nitoroglycerin in chronic conscious dogs. Cardiovasc Drugs Ther. 5:1991;131-138
21. Gibson C.M., Canon C.P., Daley W.L., et al. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation. 93:1996;879-888
22. Rentrop K.P., Cohen M., Blanke H., et al. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol. 5:1985;587-592
23. Liu Y., Sato T., O'Rourke B., et al. Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection? Circulation. 97:1998;2463-2469
24. MacGowan S.W., Regan M.C., Malone C., et al. Superoxide radical and xanthine oxidoreductase activity in the human heart during cardiac operations. Ann Thorac Surg. 60:1995;1289-1293
25. Gao W.D., Liu Y., Marban E. Selective effects of oxygen free radi-cals on excitation-contraction coupling in ventricular muscle. Implications for the mechanism of stunned myocardium. Circulation. 94:1996;2597-2604
26. Lim Y.J., Nanto S., Masuyama T., et al. Myocardial salvage: its assessment and prediction by the analysis of serial myocardial contrast echocardiograms in patients with acute myocardial infarction. Am Heart J. 128:1994;649-656
27. Ito H., Maruyama A., Iwakura K., et al. Clinical implication of the no-reflow phenomenon: a predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation. 93:1996;223-228
28. Nakae I., Matsumoto T., Horie H., et al. Effect of intravenous nicorandil on coronary circulation in humans: plasma concentration and action mechanism. J Cardiovasc Pharmacol. 35:2000;919-925